However, low protein expression level of RCC2 is associated with poor prognosis of MSS, which is attributed to its functional inhibition of tumor cell metastasis by regulating integrin α5β1-fibronectin (FN) signaling pathway (Humphries et al., 2009; Bruun et al., 2015). Here, FN1 is linked to Marinesco-Sjogren syndrome.